http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이병재,김윤근,조상헌,민경업,김유영 ( Byung Jae Lee,Yoon Keun Kim,Kyung Up Min,You Young Kim ) 대한천식알레르기학회 1998 천식 및 알레르기 Vol.18 No.3
IgE-mediated sensitization to natural rubber latex can induce immediate hypersensitivity reactions ranging from contact urticaria to life threatening anaphylaxis. Recent reports suggest that asthma is also relatively frequent manifestation of latex allergy. In this case report, lat,ex induced asthma is described in an operat.ing room nurse regularly exposed t,o latex gloves. Her latex sensitivity was detected by skin prick testing. Specific bronchial provocation test with latex extract showed an early asthmatic reaction. Her symptoms had been much improved after avoidance. Occupational asthma induced by latex may be not uncommon among health care workers.
이병재 ( Lee Byung Jae ),이윤 ( Lee Yun ) 한국구조물진단유지관리공학회 2019 한국구조물진단유지관리공학회 학술발표대회 논문집 Vol.23 No.1
In this study, the crack healing performance of concrete containing microbial - based self - healing agent for the purpose of crack crack healing was evaluated by the permeability test. As a result of the addition of the microbial culture solution to the mixed water at an alternative ratio, the permeability recovery rate increases as the substitution rate increases. It is necessary to develop a microbial concentrate and to study the application of mixed microorganisms for the purpose of increasing the rate of permeability recovery and decreasing the substitution rate of microbial solution.
천식 치료의 최신지견 ; 지속성베타2항진제(LABA)의 안전성
이병재 ( Byung Jae Lee ) 대한내과학회 2011 대한내과학회지 Vol.80 No.2
A recent meta-analysis of clinical trials found that long-acting beta2-agonists (LABA) increased life-threatening asthma exacerbations and deaths, which led to warnings concerning regular use of LABA by U.S. Food and Drug Administration (FDA). It is now obvious that LABA monotherapy in asthma increases the risk of serious adverse events. However, the risk is reduced with concomitant use of inhaled corticosteroid (ICS). Hence the FDA`s recommendations that LABA should not be used in patients whose asthma is well controlled with a medium dose of ICS, or LABA should be withdrawn once asthma control is achieved, remain still controversial. It seems reasonable to follow current guidelines which recommend the use of LABA when asthma is not controlled with ICS, although more well-designed research on the safety of LABA, especially when combined with ICS, is required. (Korean J Med 2011;80:135-138)